Medidata, a Dassault Systèmes brand and leader of clinical trial solutions to the life sciences industry, is kicking off NEXT New York 2024, its premier life sciences conference. Uniting more than ...
As the demand for advanced technology surges, DuPont will be featuring its extensive portfolio of innovative products and solutions at Electronica 2024, the world's premier trade fair for electronics, ...
Alteogen Inc. said that it has entered into an exclusive license agreement with Daiichi Sankyo (DSKYF.PK). As per the terms of the ...
Daiichi Sankyo has signed a deal worth up to $300 million with South Korean biotech Alteogen to develop a subcutaneous version of its AstraZeneca-partnered cancer drug Enhertu. Alteogen will ...
(RTTNews) - Alteogen Inc. said that it has entered into an exclusive license agreement with Daiichi Sankyo (DSKYF.PK). As per the terms of the deal, Daiichi Sankyo will acquire world-wide rights ...
Berkshire Hathaway Inc. Cl A 0.22% $1.01T Berkshire Hathaway Inc. Cl B 0.39% $1.01T VF Corp.-1.33% $7.89B Under Armour Inc. Cl C 2.09% $3.94B Under Armour Inc. Cl A 2.40% $3.94B ...
Innovative Industrial Properties Inc. 9% Cum. Conv. Redeem. Pfd. Series A 0.34% Digital Realty Trust Inc. 5.25% Cum. Conv. Pfd. Series J 0.15% Digital Realty Trust Inc. 5.2% Cum. Redeem.
Just over a decade after being acquired by Daiichi Sankyo, US biotech Plexxikon will be shuttered at the end of March, with its R&D projects transferred to other areas of the Japanese group. It's ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
South Korea’s Alteogen (Kosdaq: 196170) has signed an exclusive licensing agreement with Japanese pharmaceutical company Daiichi Sankyo (TYO: 4568) for its human hyaluronidase, ALT-B4. The two ...